A carregar...
Pharmacodynamic effects of daclizumab in the intrathecal compartment
OBJECTIVE: It was previously demonstrated that daclizumab therapy normalizes cellular cerebrospinal fluid (CSF) abnormalities typical of multiple sclerosis (MS) in the majority of treated patients. However, CSF cells represent only the mobile portion of intrathecal immune responses. Therefore, we as...
Na minha lista:
| Publicado no: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497534/ https://ncbi.nlm.nih.gov/pubmed/28695148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.427 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|